Evans David G

2 articles in GJC

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3).

Bacharach Jason, Brubaker Jacob W, Evans David G, Lu Fenghe, Odani-Kawabata Noriko, Yamabe Takaharu et al.

Am J OphthalmolFeb 202411 citationsRandomized Controlled Trial

Two studies found omidenepag isopropyl effectively lowers IOP in glaucoma/OHT, non-inferior to timolol over 3 months, with sustained 12-month efficacy, offering a new treatment option.

Full abstract PubMed

Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial.

Korenfeld Michael S, Robertson Stella M, Stein Jerry M, Evans David G, Rauchman Steven H, Sall Kenneth N et al.

Eye (Lond)Jan 202140 citationsRandomized Controlled Trial

Topical UNR844 eye drops for presbyopia were safe and significantly improved near vision, with effects sustained months after treatment, suggesting a promising non-surgical option.

Full abstract PubMed

All 2 articles loaded

Global Search

Evans David G

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3).

Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial.